S1 filings / 64
#64
| id | 64 |
|---|---|
| company_id | 8500 |
| ticker | AKTX |
| filing_date | 2026-06-26 |
| filing_url | https://www.sec.gov/Archives/edgar/data/0001541157/000149315226030330/ |
| business_description | Akari Therapeutics is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel proprietary ca... |
| total_revenue | — |
| operating_loss | — |
| cash_burn | — |
| total_assets | — |
| created_at | 2026-07-11T21:14:29.160346+00:00 |
| updated_at | 2026-07-22T09:18:48.989795+00:00 |
| total_revenue_usd | — |
| operating_loss_usd | — |
| cash_burn_usd | — |
| total_assets_usd | — |
| source_record_id | 1271 |
| tenant_id | 1 |